Literature DB >> 7790048

Active immunity to Pneumocystis carinii reinfection in T-cell-depleted mice.

A G Harmsen1, W Chen, F Gigliotti.   

Abstract

Immunocompetent C.B-17 mice were immunized against Pneumocystis carinii by several intratracheal inoculations with infective P. carinii. These mice and another group of C.B-17 mice naive to P. carinii were then depleted of CD4+ cells by treatment with both anti-CD4 and anti-Thy1 monoclonal antibodies. Both groups of mice were then challenged with an infective inoculum containing 10(7) P. carinii organisms by intratracheal instillation. The mean log10 counts of P. carinii nuclei in the lungs of the nonimmune mice were 4.98, 5.89, and 6.77 when they were killed at 4, 10, and 19 days, respectively, after challenge. The P. carinii counts in the lungs of the immune mice were significantly lower at each time point and below detectable levels at 10 and 19 days. Analysis of P. carinii DNA by PCR revealed no detectable P. carinii in the lungs of the immunized mice at either 10 or 19 days, whereas all of the nonimmunized mice contained P. carinii DNA at all time points. The sera of immune but not nonimmune mice contained P. carinii-specific immunoglobulin G. These results indicate that immunization of an immunocompetent host against P. carinii can protect against P. carinii pneumonia even after the host is depleted of CD4+ cells. In addition, the results are consistent with the possibility that antibodies were responsible for the observed protection against P. carinii.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7790048      PMCID: PMC173319          DOI: 10.1128/iai.63.7.2391-2395.1995

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  26 in total

1.  Distinction of virgin and memory T lymphocytes. Stable acquisition of the Pgp-1 glycoprotein concomitant with antigenic stimulation.

Authors:  R C Budd; J C Cerottini; C Horvath; C Bron; T Pedrazzini; R C Howe; H R MacDonald
Journal:  J Immunol       Date:  1987-05-15       Impact factor: 5.422

2.  Attempts at prophylaxis for murine Pneumocystis carinii pneumonitis.

Authors:  W T Hughes; H K Kim; R A Price; C Miller
Journal:  Curr Ther Res Clin Exp       Date:  1973-08

3.  Persistence of immunity to varicella in children with leukemia immunized with live attenuated varicella vaccine.

Authors:  A A Gershon; S P Steinberg
Journal:  N Engl J Med       Date:  1989-04-06       Impact factor: 91.245

4.  A monoclonal antibody to murine CD45R distinguishes CD4 T cell populations that produce different cytokines.

Authors:  K Bottomly; M Luqman; L Greenbaum; S Carding; J West; T Pasqualini; D B Murphy
Journal:  Eur J Immunol       Date:  1989-04       Impact factor: 5.532

5.  Serologic responses to Pneumocystis carinii antigens in health and disease.

Authors:  S L Peglow; A G Smulian; M J Linke; C L Pogue; S Nurre; J Crisler; J Phair; J W Gold; D Armstrong; P D Walzer
Journal:  J Infect Dis       Date:  1990-02       Impact factor: 5.226

6.  Conserved sequence homology of cysteine-rich regions in genes encoding glycoprotein A in Pneumocystis carinii derived from different host species.

Authors:  T W Wright; P J Simpson-Haidaris; F Gigliotti; A G Harmsen; C G Haidaris
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

7.  Class-specific antibody response to pneumococcal capsular polysaccharides in men infected with human immunodeficiency virus type 1.

Authors:  E N Janoff; J M Douglas; M Gabriel; M J Blaser; A J Davidson; D L Cohn; F N Judson
Journal:  J Infect Dis       Date:  1988-11       Impact factor: 5.226

8.  Passive immunoprophylaxis with specific monoclonal antibody confers partial protection against Pneumocystis carinii pneumonitis in animal models.

Authors:  F Gigliotti; W T Hughes
Journal:  J Clin Invest       Date:  1988-06       Impact factor: 14.808

9.  Analysis of the developmental stages of Pneumocystis carinii, in vitro.

Authors:  M T Cushion; J J Ruffolo; P D Walzer
Journal:  Lab Invest       Date:  1988-03       Impact factor: 5.662

10.  Role of alveolar macrophages in lipopolysaccharide-induced neutrophil accumulation.

Authors:  A G Harmsen
Journal:  Infect Immun       Date:  1988-08       Impact factor: 3.441

View more
  36 in total

Review 1.  Immunological features of Pneumocystis carinii infection in humans.

Authors:  P D Walzer
Journal:  Clin Diagn Lab Immunol       Date:  1999-03

2.  Oral Immunization of Mice with Live Pneumocystis murina Protects against Pneumocystis Pneumonia.

Authors:  Derrick R Samuelson; Nicholas M de la Rua; Tysheena P Charles; Sanbao Ruan; Christopher M Taylor; Eugene E Blanchard; Meng Luo; Alistair J Ramsay; Judd E Shellito; David A Welsh
Journal:  J Immunol       Date:  2016-02-10       Impact factor: 5.422

3.  Trimethoprim-sulfamethoxazole treatment does not reverse obstructive pulmonary changes in pneumocystis-colonized nonhuman primates with SHIV infection.

Authors:  Heather M Kling; Timothy W Shipley; Siobhan Guyach; Rebecca Tarantelli; Alison Morris; Karen A Norris
Journal:  J Acquir Immune Defic Syndr       Date:  2014-04-01       Impact factor: 3.731

Review 4.  Antibody immunity and invasive fungal infections.

Authors:  A Casadevall
Journal:  Infect Immun       Date:  1995-11       Impact factor: 3.441

Review 5.  Current understanding of Pneumocystis immunology.

Authors:  Michelle N Kelly; Judd E Shellito
Journal:  Future Microbiol       Date:  2010-01       Impact factor: 3.165

6.  Immunomodulatory effects of anti-CD4 antibody in host resistance against infections and tumors in human CD4 transgenic mice.

Authors:  D J Herzyk; E R Gore; R Polsky; K L Nadwodny; C C Maier; S Liu; T K Hart; A G Harmsen; P J Bugelski
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

Review 7.  New advances in understanding the host immune response to Pneumocystis.

Authors:  J Claire Hoving; Jay K Kolls
Journal:  Curr Opin Microbiol       Date:  2017-11-12       Impact factor: 7.934

8.  Susceptibility to Pneumocystis carinii infection: host responses of neonatal mice from immune or naive mothers and of immune or naive adults.

Authors:  B A Garvy; A G Harmsen
Journal:  Infect Immun       Date:  1996-10       Impact factor: 3.441

9.  Epitope mapping of a protective monoclonal antibody against Pneumocystis carinii with shared reactivity to Streptococcus pneumoniae surface antigen PspA.

Authors:  Jesse Wells; Francis Gigliotti; Patricia J Simpson-Haidaris; Constantine G Haidaris
Journal:  Infect Immun       Date:  2004-03       Impact factor: 3.441

10.  MyD88 signaling regulates both host defense and immunopathogenesis during pneumocystis infection.

Authors:  Sheila N Bello-Irizarry; Jing Wang; Carl J Johnston; Francis Gigliotti; Terry W Wright
Journal:  J Immunol       Date:  2013-11-29       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.